Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

A mixed methods study of symptom perception in patients with chronic heart failure.

Riegel B, Dickson VV, Lee CS, Daus M, Hill J, Irani E, Lee S, Wald JW, Moelter ST, Rathman L, Streur M, Baah FO, Ruppert L, Schwartz DR, Bove A.

Heart Lung. 2018 Mar - Apr;47(2):107-114. doi: 10.1016/j.hrtlng.2017.11.002. Epub 2018 Jan 3.

2.

Construct Validity of the Dissociative Experiences Scale: II. Its Relationship to Hypnotizability.

Frischholz EJ, Braun BG, Sachs RG, Schwartz DR, Lewis J, Shaeffer D, Westergaard C, Pasquotto J.

Am J Clin Hypn. 2015;57(2):102-9. doi: 10.1080/00029157.2015.967056.

PMID:
25928595
3.

Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome.

Geisler BP, Raad RA, Esaian D, Sharon E, Schwartz DR.

J Immunother Cancer. 2015 Feb 17;3:4. doi: 10.1186/s40425-015-0048-2. eCollection 2015.

4.

Facilitating the transition from physiology to hospital wards through an interdisciplinary case study of septic shock.

Li AS, Berger KI, Schwartz DR, Slater WR, Goldfarb DS.

BMC Med Educ. 2014 Apr 12;14:78. doi: 10.1186/1472-6920-14-78.

5.

A 25-year-old man with fulminant hepatic failure after treatment with corticosteroids.

Denson JL, Maller A, Beckwith CA, Schwartz DR.

Chest. 2013 Nov;144(5):1717-1719. doi: 10.1378/chest.13-1056. No abstract available.

PMID:
24189865
6.

Human resistin in chemotherapy-induced heart failure in humanized male mice and in women treated for breast cancer.

Schwartz DR, Briggs ER, Qatanani M, Sawaya H, Sebag IA, Picard MH, Scherrer-Crosbie M, Lazar MA.

Endocrinology. 2013 Nov;154(11):4206-14. doi: 10.1210/en.2013-1399. Epub 2013 Aug 27.

7.

Mediators of cognitive-behavioral therapy for insomnia: a review of randomized controlled trials and secondary analysis studies.

Schwartz DR, Carney CE.

Clin Psychol Rev. 2012 Nov;32(7):664-75. doi: 10.1016/j.cpr.2012.06.006. Epub 2012 Jul 3. Review.

PMID:
22935473
8.

Human resistin: found in translation from mouse to man.

Schwartz DR, Lazar MA.

Trends Endocrinol Metab. 2011 Jul;22(7):259-65. doi: 10.1016/j.tem.2011.03.005. Epub 2011 Apr 15. Review.

9.

Evolution combined with genomic study elucidates genetic bases of isobutanol tolerance in Escherichia coli.

Minty JJ, Lesnefsky AA, Lin F, Chen Y, Zaroff TA, Veloso AB, Xie B, McConnell CA, Ward RJ, Schwartz DR, Rouillard JM, Gao Y, Gulari E, Lin XN.

Microb Cell Fact. 2011 Mar 25;10:18. doi: 10.1186/1475-2859-10-18.

10.

Neoplasia and granulomas surrounding microchip transponders in Damaraland mole rats (Cryptomys damarensis).

Sura R, French RA, Goldman BD, Schwartz DR.

Vet Pathol. 2011 Jul;48(4):896-902. doi: 10.1177/0300985810377184. Epub 2010 Aug 19.

PMID:
20724516
11.

Adverse drug reactions resulting in hyperthermia in the intensive care unit.

McAllen KJ, Schwartz DR.

Crit Care Med. 2010 Jun;38(6 Suppl):S244-52. doi: 10.1097/CCM.0b013e3181dda0d4. Review.

PMID:
20502177
12.

A 61-year-old-man with massive intravascular hemolysis.

Uppal A, Hymes K, Schwartz DR.

Chest. 2009 Nov;136(5):1424-1427. doi: 10.1378/chest.09-0950. No abstract available.

PMID:
19892684
13.

Is depression after an acute coronary syndrome simply a marker of known prognostic factors for mortality?

Kronish IM, Rieckmann N, Schwartz JE, Schwartz DR, Davidson KW.

Psychosom Med. 2009 Sep;71(7):697-703. doi: 10.1097/PSY.0b013e3181ad2abd. Epub 2009 Jul 10.

14.

PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle.

Pagel-Langenickel I, Bao J, Joseph JJ, Schwartz DR, Mantell BS, Xu X, Raghavachari N, Sack MN.

J Biol Chem. 2008 Aug 15;283(33):22464-72. doi: 10.1074/jbc.M800842200. Epub 2008 Jun 25.

15.

Targeting the mitochondria to augment myocardial protection.

Schwartz DR, Sack MN.

Curr Opin Pharmacol. 2008 Apr;8(2):160-5. doi: 10.1016/j.coph.2007.12.008. Epub 2008 Feb 19. Review.

16.

A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus.

Pagel-Langenickel I, Schwartz DR, Arena RA, Minerbi DC, Johnson DT, Waclawiw MA, Cannon RO 3rd, Balaban RS, Tripodi DJ, Sack MN.

Am J Physiol Heart Circ Physiol. 2007 Nov;293(5):H2659-66. Epub 2007 Sep 21.

17.
18.

Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironment.

Schwartz DR, Moin K, Yao B, Matrisian LM, Coussens LM, Bugge TH, Fingleton B, Acuff HB, Sinnamon M, Nassar H, Platts AE, Krawetz SA, Linebaugh BE, Sloane BF.

Mol Cancer Res. 2007 May;5(5):443-54.

19.

Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.

Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, Hanash S, Misek DE, Katabuchi H, Williams BO, Fearon ER, Cho KR.

Cancer Cell. 2007 Apr;11(4):321-33.

20.

Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study.

Cote ML, Wenzlaff AS, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG.

Lung Cancer. 2007 Mar;55(3):255-62. Epub 2006 Dec 15.

21.

Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer.

Acuff HB, Sinnamon M, Fingleton B, Boone B, Levy SE, Chen X, Pozzi A, Carbone DP, Schwartz DR, Moin K, Sloane BF, Matrisian LM.

Cancer Res. 2006 Aug 15;66(16):7968-75.

22.

Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.

Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR.

Cancer Res. 2006 Feb 1;66(3):1354-62.

23.

CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.

Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG.

Carcinogenesis. 2005 Dec;26(12):2207-12. Epub 2005 Jul 28.

PMID:
16051642
24.

Prolonged intrathecal baclofen withdrawal syndrome. Case report and discussion of current therapeutic management.

Douglas AF, Weiner HL, Schwartz DR.

J Neurosurg. 2005 Jun;102(6):1133-6. Review.

PMID:
16028775
25.

Continuous positive airway pressure and postoperative hypoxemia.

Frangos SG, Schwartz DR.

JAMA. 2005 Jun 8;293(22):2714; author reply 2714-5. No abstract available.

PMID:
15941797
26.

Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.

Shedden KA, Kshirsagar MP, Schwartz DR, Wu R, Yu H, Misek DE, Hanash S, Katabuchi H, Ellenson LH, Fearon ER, Cho KR.

Clin Cancer Res. 2005 Mar 15;11(6):2123-31.

27.

FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development.

Chamorro MN, Schwartz DR, Vonica A, Brivanlou AH, Cho KR, Varmus HE.

EMBO J. 2005 Jan 12;24(1):73-84. Epub 2004 Dec 9.

29.

Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework.

Shedden KA, Taylor JM, Giordano TJ, Kuick R, Misek DE, Rennert G, Schwartz DR, Gruber SB, Logsdon C, Simeone D, Kardia SL, Greenson JK, Cho KR, Beer DG, Fearon ER, Hanash S.

Am J Pathol. 2003 Nov;163(5):1985-95.

30.

Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression.

Rangel LB, Sherman-Baust CA, Wernyj RP, Schwartz DR, Cho KR, Morin PJ.

Oncogene. 2003 Oct 16;22(46):7225-32.

PMID:
14562052
31.

Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.

Rangel LB, Agarwal R, D'Souza T, Pizer ES, Alò PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR, Morin PJ.

Clin Cancer Res. 2003 Jul;9(7):2567-75.

32.

Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.

Schwartz DR, Wu R, Kardia SL, Levin AM, Huang CC, Shedden KA, Kuick R, Misek DE, Hanash SM, Taylor JM, Reed H, Hendrix N, Zhai Y, Fearon ER, Cho KR.

Cancer Res. 2003 Jun 1;63(11):2913-22.

33.

Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells.

Sherman-Baust CA, Weeraratna AT, Rangel LB, Pizer ES, Cho KR, Schwartz DR, Shock T, Morin PJ.

Cancer Cell. 2003 Apr;3(4):377-86.

34.

Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas.

Wu R, Lin L, Beer DG, Ellenson LH, Lamb BJ, Rouillard JM, Kuick R, Hanash S, Schwartz DR, Fearon ER, Cho KR.

Am J Pathol. 2003 May;162(5):1603-10.

35.

Direct identification of Staphylococcus aureus from positive blood culture bottles.

Oliveira K, Brecher SM, Durbin A, Shapiro DS, Schwartz DR, De Girolami PC, Dakos J, Procop GW, Wilson D, Hanna CS, Haase G, Peltroche-Llacsahuanga H, Chapin KC, Musgnug MC, Levi MH, Shoemaker C, Stender H.

J Clin Microbiol. 2003 Feb;41(2):889-91.

36.

A protein molecular weight map of ES2 clear cell ovarian carcinoma cells using a two-dimensional liquid separations/mass mapping technique.

Wang H, Kachman MT, Schwartz DR, Cho KR, Lubman DM.

Electrophoresis. 2002 Sep;23(18):3168-81.

PMID:
12298089
37.

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, Cho KR.

Cancer Res. 2002 Aug 15;62(16):4722-9.

38.
39.

A 2-D liquid separations/mass mapping method for interlysate comparison of ovarian cancers.

Kachman MT, Wang H, Schwartz DR, Cho KR, Lubman DM.

Anal Chem. 2002 Apr 15;74(8):1779-91.

PMID:
11985308
40.

Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas.

Zhai Y, Wu R, Schwartz DR, Darrah D, Reed H, Kolligs FT, Nieman MT, Fearon ER, Cho KR.

Am J Pathol. 2002 Apr;160(4):1229-38.

41.

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles.

Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JM, Lee N, Misek DE, Greenson JK, Kardia SL, Beer DG, Rennert G, Cho KR, Gruber SB, Fearon ER, Hanash S.

Am J Pathol. 2001 Oct;159(4):1231-8.

42.

Coordinately up-regulated genes in ovarian cancer.

Hough CD, Cho KR, Zonderman AB, Schwartz DR, Morin PJ.

Cancer Res. 2001 May 15;61(10):3869-76.

43.

Cysteine 73 in bleomycin hydrolase is critical for amyloid precursor protein processing.

Lefterov IM, Koldamova RP, Lefterova MI, Schwartz DR, Lazo JS.

Biochem Biophys Res Commun. 2001 May 18;283(4):994-9.

PMID:
11350084
44.

Treatment of oxygen-induced hypercapnia.

Malhotra A, Schwartz DR, Ayas N, Stanchina M, White DP.

Lancet. 2001 Mar 17;357(9259):884-5. No abstract available.

PMID:
11265981
45.

Lung recruitment.

Kacmarek RM, Schwartz DR.

Respir Care Clin N Am. 2000 Dec;6(4):597-623. Review.

PMID:
11172579
46.

Microcirculatory weak units--an alternative explanation.

Schwartz DR, Malhotra A, Fink MP.

Crit Care Med. 2000 Aug;28(8):3127-9. No abstract available.

PMID:
10966332
47.

Feather folliculoma in a captive-bred barn owl (Tyto alba).

Frasca S Jr, Schwartz DR, Moiseff A, French RA.

Avian Dis. 1999 Jul-Sep;43(3):616-21.

PMID:
10494437
48.

Negative pressure pulmonary hemorrhage.

Schwartz DR, Maroo A, Malhotra A, Kesselman H.

Chest. 1999 Apr;115(4):1194-7.

PMID:
10208229
49.

The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance.

Schwartz DR, Homanics GE, Hoyt DG, Klein E, Abernethy J, Lazo JS.

Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4680-5.

50.

Doris Schwartz: a creative role for faculty in community health.

Schwartz DR.

Geriatr Nurs. 1997 Mar-Apr;18(2):83-4. No abstract available.

PMID:
9119279

Supplemental Content

Loading ...
Support Center